XONA MICROFLUIDICS® specializes in providing scientists microfluidic platforms for measuring and manipulating neurons. Our products offers axon isolation, compartmentalization, fluidic isolation, and improved organization over traditionally chaotic neuronal cell culture.

Our expert team includes neuroscientists with critical experience designing and conducting research. Xona has been awarded numerous NIH grants and, in 2020, began offering contract research services.

Xona holds the original, exclusive license to sell compartmentalized microfluidic devices, originally described in Nature Methods (2005). Dr. Anne Taylor, an inventor, is Xona’s Chief Scientific Officer.

Our microfluidic devices enable the unique study of neuronal subcellular compartments and lead to the development of valuable in vitro models of the NMJ and other co-culture innervation models. Our devices are used extensively for Alzheimer’s disease, ALS, and Parkinson’s disease research.

Xona’s time-tested technology has been cited in over 1,000 publications. Many of these publications can be found on our publications page.

Both primary neurons and human iPSC-derived neurons can be easily cultured within our platforms. Neurons can be cultured for 21 or more days. Xona Microfluidics® sells both the original Silicone (PDMS) Devices as well as our newer XonaChips® which are made of optically transparent cyclic olefin copolymer.

Xona Microfluidics

Org chart

Teams

Offices